Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 52, 1195-1200, March 1, 1992]
© 1992 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dumont, J. A.
Right arrow Articles by Bitonti, A. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dumont, J. A.
Right arrow Articles by Bitonti, A. J.

Inhibition of Experimental Metastasis and Cell Adhesion of B16F1 Melanoma Cells by Inhibitors of Protein Kinase C

Jennifer A. Dumont1, Winton D. Jones, Jr. and Alan J. Bitonti

Marion Merrell Dow Research Institute, Cincinnati, Ohio 45215

Phorbol esters which activate protein kinase C (PKC) have been shown to enhance experimental lung metastasis. Therefore, it was reasoned that inhibitors of PKC might also modulate metastasis. We have investigated this possibility using a PKC inhibitor, MDL 27,032 [4-propyl-5(4-pyridinyl)-2(3H)-oxazolone], as well as staurosporine and H-7. Treatment of B16F1 murine melanoma cells with MDL 27,032 for 24 h in culture and subsequent i.v. injection of the cells into mice resulted in >90% inhibition of lung metastasis. Inhibition of metastasis was time dependent, with 90% of maximum inhibition occurring by 8 h of incubation. The 50% inhibitory concentration (IC50) for inhibition of metastasis with MDL 27,032 was 7 µM, a value similar to that for the inhibition of B16F1 membrane-associated PKC (IC50 = 13 µM) but not cytosolic PKC (IC50 = 54 µM). B16F1 cells treated with MDL 27,032 for 24 h were less adherent than untreated cells to extracellular matrix/basement membrane proteins. Adhesion to fibrinogen and collagen IV was inhibited (IC50 = 6 µM and 48 µM, respectively) by MDL 27,032, whereas adherence to laminin and fibronectin was not affected, indicating that the drug affects specific adhesion molecules. MDL 27,032-treated cells were also found to be less adherent than untreated cells to human umbilical vein endothelial cells. The phosphorylation of an 80-kDa B16F1 cell plasma membrane protein was stimulated under conditions known to stimulate PKC activity, and MDL 27,032 inhibited this phosphorylation in a dose-dependent manner. MDL 27,032 was more potent than H-7 for the inhibition of metastasis but was significantly less potent than staurosporine. These results support the hypothesis that there is a critical role for PKC-mediated phosphorylation of cell surface adhesion receptors in metastasis.

1 To whom requests for reprints should be addressed, at Marion Merrell Dow Research Institute, 2110 E. Galbraith Road, Cincinnati, OH 45215.

Received 7/24/91. Accepted 12/16/91.




This article has been cited by other articles:


Home page
Cell Growth Differ.Home page
E. Sanz-Navares, N. Fernandez, M. G. Kazanietz, and S. A. Rotenberg
Atypical Protein Kinase C{zeta} Suppresses Migration of Mouse Melanoma Cells
Cell Growth Differ., October 1, 2001; 12(10): 517 - 524.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
R. Palmantier, M. D. George, S. K. Akiyama, F. M. Wolber, K. Olden, and J. D. Roberts
cis-Polyunsaturated Fatty Acids Stimulate {beta}1 Integrin-mediated Adhesion ofHuman Breast Carcinoma Cells to Type IV Collagen by Activating ProteinKinases C-{{epsilon}} and -{micro}
Cancer Res., March 1, 2001; 61(6): 2445 - 2452.
[Abstract] [Full Text]


Home page
J. Histochem. Cytochem.Home page
J. Szalay, P. Bruno, R. Bhati, J. Adjodha, D. Schueler, V. Summerville, and R. Vazeos
Associations of PKC Isoforms with the Cytoskeleton of B16F10 Melanoma Cells
J. Histochem. Cytochem., January 1, 2001; 49(1): 49 - 66.
[Abstract] [Full Text]


Home page
Mol. Pharmacol.Home page
R. M. Sullivan, M. Stone, J. F. Marshall, F. Uberall, and S. A. Rotenberg
Photo-Induced Inactivation of Protein Kinase Calpha by Dequalinium Inhibits Motility of Murine Melanoma Cells
Mol. Pharmacol., October 1, 2000; 58(4): 729 - 737.
[Abstract] [Full Text]


Home page
J. Immunol.Home page
M. Kobayashi, H. Kobayashi, R. B. Pollard, and F. Suzuki
A Pathogenic Role of Th2 Cells and Their Cytokine Products on the Pulmonary Metastasis of Murine B16 Melanoma
J. Immunol., June 15, 1998; 160(12): 5869 - 5873.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
X. Ouyang, T. Gulliford, H. Zhang, G. C. Huang, and R. Epstein
Human Cancer Cells Exhibit Protein Kinase C-dependent c-erbB-2 Transmodulation That Correlates with Phosphatase Sensitivity and Kinase Activity
J. Biol. Chem., September 6, 1996; 271(36): 21786 - 21792.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Tsuchida, Y. Aoyagi, S. Odani, T. Mita, and M. Isemura
Isolation of a Novel Collagen-binding Protein from the Mushroom, Hypsizigus marmoreus, Which Inhibits the Lewis Lung Carcinoma Cell Adhesion to Type IV Collagen
J. Biol. Chem., January 27, 1995; 270(4): 1481 - 1484.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1992 by the American Association for Cancer Research.